CANCER CARE ONTARIO PROGRAM IN EVIDENCE-BASED CARE [Français]
- Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy, revised 2003
[full text - pdf]
[quick reference - pdf]
- Adjuvant care for stage I ovarian cancer, 2004
[full text - pdf]
[quick reference - pdf]
- Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults, revised 2005
[full text - pdf]
[quick reference - pdf]
- Use of adjuvant chemotherapy following cystectomy in patients with deep muscle-invasive transitional cell carcinoma of the bladder, 2003
[full text - pdf]
[quick reference - pdf]
- Adjuvant chemotherapy or radiotherapy for resectable pancreatic adenocarcinoma : a clinical practice guideline, 2006
[full text - pdf]
- Adjuvant radiotherapy in women with stage I endometrial cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)]
[guideline development, external review, methods, and results - pdf] (see section 3)
- Adjuvant systemic chemotherapy, following surgery and external beam radiotherapy, for adults with newly diagnosed malignant glioma : a clinical practice guideline, revised 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Adjuvant systemic therapy for node-negative breast cancer, revised 2002 (reviewed 2003)
[full text - pdf]
[quick reference - pdf]
- Adjuvant taxane therapy for women with early-stage, invasive breast cancer: a clinical practice guideline, 2007
[full text - pdf]
[summary and full text - pdf] - Alemtuzumab in chronic lymphocytic leukemia : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Use of amifostine to ameliorate the toxic effects of chemotherapy in the treatment of cancer, revised 2003
[full text - pdf]
[quick reference - pdf]
- The role of amifostine as a radioprotectant in the management of patients with squamous cell head and neck cancer, 2003 (reviewed 2004)
[full text - pdf]
[quick reference - pdf]
- The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer : a clinical practice guideline, revised 2007
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer, revised 2003
[full text - pdf]
[quick reference - pdf]
- Baseline staging tests in primary breast cancer, revised 2002, (reviewed 2003)
[full text - pdf]
[quick reference - pdf]
- The role of Bevacizumab (Avastin™) combined with chemotherapy in the treatment of patients with advanced colorectal cancer : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The use of bisphosphonates in men with hormone-refractory prostate cancer, 2005
[full text - pdf]
[quick reference - pdf]
- The role of bisphosphonates in the management of skeletal complications for patients with multiple myeloma, 2004
[full text - pdf]
[quick reference - pdf]
- Use of bisphosphonates in women with breast cancer, revised 2004
[full text - pdf]
[quick reference - pdf]
- Bortezomib in multiple myeloma and lymphoma : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Capecitabine in stage IV breast cancer, 2003
[full text - pdf]
[quick reference - pdf]
- Cervical screening, 2005
[full text - pdf]
- The use of chemotherapy and growth factors in older patients with newly diagnosed, advanced-stage, aggressive histology Non-Hodgkin's lymphoma, 2003
[full text - pdf]
[quick reference - pdf]
- Chemotherapy for recurrent, metastatic, or persistent cervical cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Chemotherapy for relapsed small cell lung cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The use of chemotherapy in patients with advanced malignant pleural mesothelioma : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Chemotherapy in stage IV (metastatic) non-small cell lung cancer, revised 2002 (reviewed 2003)
[full text - pdf]
[quick reference - pdf]
- Chemotherapy with radiotherapy for nasopharyngeal cancer : a clinical practice guideline, revised 2004
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of colony-stimulating factor (CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer, 2003
[full text - pdf]
[quick reference - pdf]
- The role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer, revised 2003 (reviewed 2003)
[full text - pdf]
[quick reference - pdf]
- Combined modality radiotherapy and chemotherapy in the non-surgical management of localized carcinoma of the esophagus, revised 2003 (reviewed 2005)
[full text - pdf]
[quick reference - pdf]
- Cross-sectional diagnostic imaging in lung cancer, 2006
[full text - pdf]
- Cross-sectional imaging in colorectal cancer, 2006
[full text - pdf]
- The role of cytoreductive nephrectomy in metastatic renal cell cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Use of Dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer, revised 2002 (reviewed 2004)
[full text - pdf]
[quick reference - pdf]
- Diagnostic imaging in breast cancer, 2006
[full text - pdf]
- Diagnostic imaging in lymphoma, 2006
[full text - pdf]
- Diagnostic imaging in the assessment of metastatic and recurrent ovarian cancer, 2006
[full text - pdf]
- Dose-intensive chemotherapy with growth factor or autologous bone marrow / stem cell transplant support in the first-line treatment of advanced or metastatic adult soft tissue sarcoma : a practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma, revised 2001 (reviewed 2004)
[full text - pdf]
[quick reference - pdf]
- Use of the epidermal growth factor receptor inhibitors, Gefitinib (Iressa®) and Erlotinib (Tarceva®), in the treatment of non-small cell lung cancer : a clinical practice guideline, revised 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Epirubicin, as a single agent or in combination, for metastatic breast cancer, revised 2002 (reviewed 2003)
[full text - pdf]
[quick reference - pdf]
- The role of erythropoietin in the management of cancer patients with non-hematologic malignancies receiving chemotherapy, revised 2005
[full text - pdf]
[quick reference - pdf]
- First-line chemotherapy for postoperative patients with stage II, III or IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, revised 2004
[full text - pdf]
[quick reference - pdf]
- Follow-up after primary therapy for endometrial cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Follow-up of patients with curatively resected colorectal cancer, revised 2004
[full text - pdf]
[quick reference - pdf]
- Use of gemcitabine in non-small-cell lung cancer, 2002 (reviewed 2005)
[full text - pdf]
[quick reference - pdf]
- The role of Gemcitabine in the management of metastatic breast cancer : a clinical practice guideline, revised 2007
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma, revised 2005
[full text - pdf]
[quick reference - pdf]
- The role of Gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer, 2005
[full text - pdf]
[quick reference - pdf]
- The role of HER2/neu in systemic and radiation therapy for women with breast cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of high dose rate brachytherapy in the palliation of patients with non-small cell lung cancer : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Hyperfractionated radiotherapy for locally advanced squamous cell carcinoma of the head and neck, revised 2003
[full text - pdf]
[quick reference - pdf]
- Ibritumomab tiuxetan in lymphoma : a clinical practice guideline, revised 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Imatinib Mesylate (Gleevec TM) for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Interleukin-2 in the treatment of patients with unresectable or metastatic renal cell cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Iodine-131 tositumomab in lymphoma: a clinical practice guideline, 2007
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Use of irinotecan (Camptosar®, CPT-11) combined with 5-Fluorouracil and Leucovorin (5FU/LV) as first-line therapy for metastatic colorectal cancer, 2003
[full text - pdf]
[quick reference - pdf]
- Use of irinotecan in the second-line treatment of metastatic colorectal carcinoma, revised 2004
[full text - pdf]
[quick reference - pdf]
- Laparoscopic surgery for cancer of the colon : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Liposomal anthracyclines in the management of patients with HIV-positive Kaposi's sarcoma, 2002 (reviewed 2004)
[full text - pdf]
[quick reference - pdf]
- Magnetic Resonance imaging screening of women at high risk for breast cancer : a clinical practice guideline, 2007
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Management of brain metastases : role of radiotherapy alone or in combination with other treatment modalities, 2004
[full text - pdf]
[quick reference - pdf]
- Management of ductal carcinoma in situ of the breast: a clinical practice guideline, revised 2006
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Management of single brain metastases, 2004
[full text - pdf]
[quick reference - pdf]
- Management of unresected stage III non-small cell lung cancer : a clinical practice guideline, revised 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Maximal androgen blockade for the treatment of metastatic prostate cancer, 2003
[full text - pdf]
[quick reference - pdf]
- Neoadjuvant or adjuvant therapy for resectable esophageal cancer, revised 2005
[full text - pdf]
[quick reference - pdf]
- Neoadjuvant or adjuvant therapy for resectable gastric cancer, revised 2002 (reviewed 2003)
[full text - pdf]
[quick reference - pdf]
- The role of neoadjuvant chemotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck (excluding nasopharynx), revised 2003
[full text - pdf]
[quick reference - pdf]
- Use of neoadjuvant chemotherapy in transitional cell carcinoma of the bladder, 2005 (Version 2.2005)
[full text - pdf]
[quick reference - pdf]
- The role of neurokinin-1 receptor antagonists in the prevention of emesis due to high-dose cysplatin : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Non-hormonal systemic therapy in men with metastatic hormone-refractory prostate cancer : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of octreotide in the management of patients with cancer, revised 2004
[full text - pdf]
[quick reference - pdf]
- The optimal chemotherapy treatment for women with recurrent ovarian cancer: a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Optimal therapy for patients diagnosed with multiple myeloma and the role of high-dose chemotherapy and stem cell support, revised 2003
[full text - pdf]
[quick reference - pdf]
- Oral capecitabine (Xeloda TM) in the first-line treatment of metastatic colorectal cancer : a clinical practice guideline, revised 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of photodynamic therapy (PDT) in patients with non-small cell lung cancer : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of Porfimer Sodium (Photofrin TM) in the ablation of high-grade dysplasia associated with Barrett's esophagus, 2006
[full text - pdf]
[quick reference - pdf]
- The role of Porfimer Sodium (Photofrin TM) in the palliative treatment of esophageal cancer, 2006
[full text - pdf]
[quick reference - pdf]
- Postoperative adjuvant chemotherapy, with or without radiotherapy, in completely resected non-small cell lung cancer : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer, revised 2005
[full text - pdf]
[quick reference - pdf]
- The role of postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck : a clinical practice guideline : section 1, 2004
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer, revised 2004
[full text - pdf]
[quick reference - pdf]
- The prevention and management of acute skin reactions related to radiation therapy : a clinical practice guideline, revised 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Primary treatment for locally advanced cervical cancer : concurrent platinum-based chemotherapy and radiation, revised 2004
[full text - pdf]
[quick reference - pdf]
- Prophylactic cranial irradiation in small cell lung cancer, revised 2002 (reviewed 2003)
[full text - pdf]
[quick reference - pdf]
- The role of radiation therapy in malignant pleural mesothelioma : a clinical practice guideline, 2006
[full text - pdf]
- Radiopharmaceuticals for the palliation of painful bone metastases, 2004
[full text - pdf]
[quick reference - pdf]
- Radiotherapy for newly diagnosed malignant glioma in adults, revised 2004
[full text - pdf]
[quick reference - pdf]
- Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases, 2003
[full text - pdf]
[quick reference - pdf]
- Use of Raltitrexed (Tomudex) in the management of metastatic colorectal cancer, revised 2001 (reviewed 2005)
[full text - pdf]
[quick reference - pdf]
- Rituximab in lymphoma and chronic lymphocytic leukemia : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development and review : methods and results - pdf]
- Screening for skin cancer : a clinical practice guideline, 2007
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Self-collected samples for testing of oncogenic human papillomavirus : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of single-agent Docetaxel (Taxotere®) as a second-line treatment for advanced non-small-cell lung cancer, 2001 (reviewed 2004)
[full text - pdf]
[quick reference - pdf]
- Single-agent interleukin-2 in the treatment of metastatic melanoma : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Surgical management of early-stage invasive breast cancer, 2003
[full text - pdf]
[quick reference - pdf]
- Surgical management of malignant pleural mesothelioma : a clinical practice guideline, 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Symptomatic treatment of radiation-induced xerostomia in head and neck cancer patients, revised 2002 (reviewed 2004)
[full text - pdf]
[quick reference - pdf]
- Systemic adjuvant therapy for patients at high risk for recurrent melanoma : a clinical practice guideline, revised 2005
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Systemic therapy for advanced or recurrent endometrial cancer, and advanced or recurrent uterine papillary serous carcinoma, 2004
[full text - pdf]
[quick reference - pdf]
- The role of taxanes in the management of metastatic breast cancer, 2003
[full text - pdf]
[quick reference - pdf]
- The role of taxanes in first-line therapy of advanced non-small cell lung cancer, 2004
[full text - pdf]
[quick reference - pdf]
- The role of taxanes in neoadjuvant chemotherapy for women with non-metastatic breast cancer, 2004
[full text - pdf]
[quick reference - pdf]
- Temozolomide for the treatment of metastatic melanoma : a clinical practice guideline, 2006
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer, revised 2003
[full text - pdf]
[quick reference - pdf]
- The role of trastuzumab in adjuvant and neoadjuvant therapy in women with HER2/neu-overexpressing breast cancer : a clinical practice guideline, revised 2007
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
- Treatment of chronic myeloid leukemia with imatinib, 2004
[full text - pdf]
[quick reference - pdf]
- The Treatment of locally advanced pancreatic cancer, revised 2004
[full text - pdf]
[quick reference - pdf]
- Treatment for anemia with erythropoietic agents in patients with non-myeloid hematological malignancies: a clinical practice guideline-, 2007
[full text - pdf]
[systematic review - pdf] (see section 2)
[guideline development, external review, methods, and results - pdf] (see section 3)
Last updated: 31 March 2008